AMC Entertainment heads into its August 4 earnings report with short interest rebuilding modestly, borrow conditions loose, and the Street still leaning skeptical — a setup that leaves bulls pointing to a blockbuster-driven recovery story while bears see a company still fighting its debt load.
Short interest tells a story of stubborn, structural pressure rather than acute squeeze risk. At 11.8% of the free float — roughly 60.4 million shares short — the position is elevated but has drifted lower over the past month, down about 5% from early June levels above 64 million shares. The tick-up on July 7 (about 1.3% day-on-day) is a minor rebuild, not a new offensive. Crucially, the borrow market is wide open: availability is running at over 515%, meaning there are more than five shares available to borrow for every share already lent out. That compares to a 52-week minimum availability of just 0.05% — a reminder of how different today's lending conditions are from prior stress periods. Cost to borrow has crept up about 7% on the week to 0.59%, but in absolute terms it remains near zero. Shorts face no meaningful squeeze pressure in the lending market.
Options positioning reinforces the calm. The put/call ratio is running just above its 20-day average at 0.19 — barely half a standard deviation from normal — and nowhere near its 52-week high of 0.31. That suggests options traders aren't loading up on either downside protection or speculative calls ahead of the print. The ORTEX short score sits at 46.3, marginally higher on the week but well below the mid-60s readings seen earlier in the year, consistent with a stock where the short thesis has cooled without fully reversing.
The analyst picture is mixed but fractionally more constructive this week. Macquarie's Chad Beynon raised his target to $2.00 from $1.50 on July 8, maintaining a Neutral rating — still below the current $1.72 price. Benchmark holds the lone Buy with a $2.50 target, while Citigroup remains at Sell with a $1.20 target. The consensus mean target of $2.16 implies modest upside from here. Bulls point to projected 53% EBITDA growth in 2026 and margin expansion from roughly 8% toward 12% by 2027, driven by a stronger summer film slate. Bears counter that the company's revised revenue guidance of $955 million still reflects persistent attendance headwinds, the net leverage ratio remains heavy at 9.3x, and quantitative screens flag overvaluation relative to peers. The forward EPS momentum factor scores near the bottom of the universe — third percentile over both 30 and 90 days — while the 12-month forward EPS year-on-year improvement score sits at a respectable 86th percentile, capturing the tension between near-term pressure and longer-horizon recovery expectations.
The most genuinely interesting data point from the week is inside the institutional register. Discovery Capital Management holds 55.5 million shares — 6.2% of outstanding — as the largest disclosed holder, well ahead of BlackRock's 40.2 million. Discovery added more than 9 million shares in its last reported period. That's an active-manager bet of real size in a company with a market cap that has essentially no room for error. On the insider side, CEO Adam Aron purchased 250,000 shares at $1.38 in May — a $344,000 open-market buy, meaningful as a signal but modest relative to a previous January sell of 283,000 shares at $1.45. Net 90-day insider activity is a small positive.
The recent earnings history adds texture heading into August. The May 2026 print produced a sharp one-day gain of 13%, but the stock gave back all of it and more over the following five days, falling 7.6% on the week. The print before that moved the opposite way — down 4.4% on day one and down 16.4% over five days. Two data points are thin, but the pattern of violent initial reactions followed by reversals is worth holding in mind as the August 4 date approaches.
The next four weeks narrow to a single question: whether the summer blockbuster slate translates into attendance numbers that support the EBITDA recovery narrative — with peer CNK down 10% on the week and MCS off 7.5% suggesting the sector is not getting the benefit of the doubt right now.
See the live data behind this article on ORTEX.
Open AMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
